Skip to main content
Year archive

AFT PHARMACEUTICALS LIMITED — 2021 filings

All 47 regulatory filings released by AFT PHARMACEUTICALS LIMITED (AFP) in 2021, sourced directly from the official regulator.

47 Filings
2021 Period
2021 filings (47)
Filing Released Lang
Disclosure of Directors and Senior Managers Relevant Interes 2 pages 287.2KB
Director's Dealing
2021-12-21 English
AFT welcomes Australian Federal Court appeal success 1
Legal Proceedings Report
2021-12-08 English
Application for quotation of securities - AFP 6 pages 27.1KB
Share Issue/Capital Change
2021-12-08 English
capital change notice 2 pages 137.8KB
Share Issue/Capital Change
2021-12-06 English
Application for quotation of securities - AFP 6 pages 27.1KB
Share Issue/Capital Change
2021-12-06 English
amended capital notice 2 pages 137.8KB
Share Issue/Capital Change
2021-12-06 English
211118 AFT 1H FY22 Market Release 10 pages 231.6KB
Interim / Quarterly Report
2021-11-17 English
211118 AFT FY 22 Interim Result Investor Presentation 27 pages 2.6MB
Investor Presentation
2021-11-17 English
211118 AFT Interim Financial Statements FY22 23 pages 2.0MB
Interim / Quarterly Report
2021-11-17 English
211118 AFT Interim Announcement FY2022 App2 2 pages 201.6KB
Earnings Release
2021-11-17 English
Presentation Slide 16 Correction 27 pages 2.6MB
Investor Presentation
2021-11-17 English
FDA confirms earlier than expected PDUFA date for Maxigesic 2 pages 149.2KB
Regulatory Filings
2021-11-14 English
AFT appoints McPhersons as Singapore distributor 2 pages 130.0KB
Capital/Financing Update
2021-11-04 English
US FDA accepts Maxigesic IV New Drug Application 3 pages 173.8KB
Capital/Financing Update
2021-10-31 English
Maxigesic IV registered in the UK and Ireland 2 pages 159.5KB
Regulatory Filings
2021-10-18 English
half year interim results announcement 18 Nov 2021 1
Report Publication Announcement
2021-10-11 English
AFT further extends Maxigesic footprint strengthens EU 2 pages 167.4KB
Capital/Financing Update
2021-09-20 English
Change of Capital notice 2 pages 136.0KB
Share Issue/Capital Change
2021-09-05 English
ASM chairs address 6 pages 174.7KB
AGM Information
2021-08-05 English
ASM presentation 49 pages 3.6MB
AGM Information
2021-08-05 English
ASM 2021 results 1 page 150.3KB
Declaration of Voting Results & Voting Rights Announcements
2021-08-05 English
New clinical study Novaliq NovaTears Omega-3 eye drops 3 pages 185.6KB
Regulatory Filings
2021-07-28 English
Maxigesic Oral Liquid gets first regulatory approval 3 pages 137.2KB
Regulatory Filings
2021-07-13 English
Capital Change Notice - Issue of ordinary shares 2 pages 149.4KB
Share Issue/Capital Change
2021-07-13 English
D&O Ongoing Disclosure - Louise Clayton 1 page 260.
Director's Dealing
2021-07-13 English
Application for quotation of securities - AFP 6 pages 28.2KB
Share Issue/Capital Change
2021-07-13 English
ASM 2021 Proxy form 2 pages 96.2KB
AGM Information
2021-07-07 English
Maxigesic IV launches in Germany and Austria 3 pages 136.0KB
Regulatory Filings
2021-07-07 English
Notice of Annual Meeting of Shareholders 2021 4 pages 436.8KB
AGM Information
2021-07-05 English
Application for quotation of securities - AFP 6 pages 28.0KB
Share Issue/Capital Change
2021-06-23 English
Appendix 2A 16 pages 305.2KB
Capital/Financing Update
2021-06-22 English
Capital Change Notice 2 pages 149.4KB
Share Issue/Capital Change
2021-06-20 English
FY2021 Announcement 6 pages 205.0KB
Annual Report
2021-05-23 English
FY2021 Announcement App 2 2 pages 189.6KB
Earnings Release
2021-05-23 English
FY2021 Annual Report 44 pages 3.1MB
Annual Report
2021-05-23 English
FY 2021 AFT Financial Presentation 17 pages 1.5MB
Investor Presentation
2021-05-23 English
Appendix 2A 15 pages 300.9KB
Regulatory Filings
2021-05-11 English
AFT extends Maxigesic IV license in South America 2 pages 162.9KB
Capital/Financing Update
2021-05-04 English
AFT Pharmaceuticals to announce full year results on Monday 2 pages 67.5KB
Report Publication Announcement
2021-05-03 English
Capital change notice - issue of shares 2 pages 111.5KB
Share Issue/Capital Change
2021-05-02 English
AFT licenses Maxigesic IV in the US 4 pages 146.5KB
Capital/Financing Update
2021-04-27 English
Crystawash Extend distribution in UAE, Kuwait, Oman and Ken 3 pages 189.1KB
Regulatory Filings
2021-04-11 English
AFT secures new partners in Poland and Greece 2 pages 131.7KB
Capital/Financing Update
2021-04-06 English
AFT updates earnings guidance 2 pages 130.0KB
Earnings Release
2021-03-31 English
AFT licenses Pascomer for Europe 2 pages 131.6KB
Regulatory Filings
2021-03-16 English
MAXIGESIC IV LICENSED IN EIGHT NEW EUROPEAN MARKETS 3 pages 202.0KB
Capital/Financing Update
2021-03-04 English
24-hour efficacy for Crystawash Extend Hand Sanitiser 2 pages 152.4KB
Regulatory Filings
2021-01-10 English